Karen Reeves
Corporate Officer/Principal chez LIGAND PHARMACEUTICALS INCORPORATED
Postes actifs de Karen Reeves
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 20/02/2024 | - |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Directeur Technique/Scientifique/R&D | 01/09/2017 | - |
| President | 01/09/2017 | - |
Historique de carrière de Karen Reeves
Anciens postes connus de Karen Reeves
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KIROMIC BIOPHARMA, INC. | Directeur/Membre du Conseil | 14/02/2022 | 06/12/2022 |
| Independent Dir/Board Member | 14/02/2022 | 06/12/2022 | |
| MEDIVATION INC | Corporate Officer/Principal | 18/12/2009 | 29/03/2010 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Formation de Karen Reeves
| Yale University | Undergraduate Degree |
| University of Vermont College of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Japon | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Karen Reeves
- Expérience